Cancer in mice just got deadlier thanks to Harvard instructor Tan Ince, and humans with breast cancer may benefit. Ince developed a recipe that turns normal cells into breast cancer stem cells -- the kind that can initiate tumors and spread.
Cancer stem cells are difficult to isolate from tissue biopsies as they are exceedingly rare -- about one in a million, Ince told HealthDay News. Their importance cannot be understated, as cancers that spread to other areas of the body (metastatic cancers) are responsible for the majority of cancer deaths. (Cancers metastasize when a cancer stem cell "breaks off" of the tumor and travels through the body to another location.)
Tumor cell lines that pharmaceutical companies have been testing their drug candidates on lack a significant number of cancer stem cells, so their effect could only be tested superficially in petri dishes. Ince's recipe produces a high percentage of these deadly cells, with the result of as "many as one in ten is a cancer stem cell," according to MIT.
Ince's recipe allows researchers to grow tissue with a significantly higher number of cancer stem cells, allowing companies to more rapidly screen for stem cell killing drugs; kill the cancer stem cells, kill the cancer -- or so the hope goes.
Exactly how deadly are these cells?
Ouch.
Scientists Create Breast Tumor Stem Cells [HealthDay News]